Department of Chemistry, Korea University, 02841, Seoul, Republic of Korea.
Fluorescence Research Group, Singapore University of Technology and Design, 487372, Singapore, Singapore.
Angew Chem Int Ed Engl. 2023 Aug 7;62(32):e202307797. doi: 10.1002/anie.202307797. Epub 2023 Jun 29.
Photoacoustic imaging (PAI), a state-of-the-art noninvasive in vivo imaging technique, has been widely used in clinical disease diagnosis. However, the design of high-performance PAI agents with three key characteristics, i.e., near-infrared (NIR) absorption (λ >800 nm), intense PA signals, and excellent photostability, remains a challenging goal. Herein, we present a facile but effective approach for engineering PAI agents by amplifying intramolecular low-frequency vibrations and enhancing the push-pull effect. As a demonstration of this blended approach, we constructed a PAI agent (BDP1-NEt ) based on the boron-dipyrromethene (BODIPY) scaffold. Compared with indocyanine green (ICG, an FDA-approved organic dye widely utilized in PAI studies; λ =788 nm), BDP1-NEt exhibited a UV/Vis-NIR spectrum peaked at 825 nm, superior in vivo PA signal intensity and outstanding stability to offer improved tumor diagnostics. We believe this work provides a promising strategy to develop the next generation of PAI agents.
光声成象(PAI)是一种先进的非侵入式活体成像技术,已广泛应用于临床疾病诊断。然而,设计具有三个关键特性的高性能 PAI 试剂仍然是一个具有挑战性的目标,这三个关键特性分别是近红外(NIR)吸收(λ>800nm)、强烈的 PA 信号和优异的光稳定性。在此,我们提出了一种通过放大分子内低频振动和增强推挽效应来设计 PAI 试剂的简单而有效的方法。作为这种混合方法的演示,我们基于硼二吡咯甲烷(BODIPY)支架构建了一种 PAI 试剂(BDP1-NEt)。与吲哚菁绿(ICG,一种已获得 FDA 批准的有机染料,广泛用于 PAI 研究;λ=788nm)相比,BDP1-NEt 在 825nm 处具有 UV/Vis-NIR 光谱,具有更高的体内 PA 信号强度和出色的稳定性,可为肿瘤诊断提供改进。我们相信这项工作为开发下一代 PAI 试剂提供了有前途的策略。